Lumenis: Ophthalmology
  
eSeminar Schedule
eSeminar Schedule
SLT eSeminar

dotsWhat

August 14, 2008 5:00 PM PST / 8:00 PM EST - click to register now

Selecta® SLT - eSeminar is intended for those participants familiar with the SLT
procedure for the treatment of Open Angle Glaucoma

Topics will include:

  • Fundamentals of SLT
  • Review of latest SLT studies that promote better quality of life and cost savings for POAG patients
  • Review of clinical applications
  • Integrating SLT into your clinical practice
  • Financial considerations regarding this therapy

This eSeminar will be conducted over the Internet. Participants will need a computer connected to the Internet and a phone line for the audio portion of the presentation (toll free within the USA).


Speaker: Brian A. Francis, M.D., M.S.

Associate Professor of Ophthalmology;
Ralph and Angelyn Riffenburgh Professorship of Glaucoma
Doheny Eye Institute, Keck School of Medicine,
University of Southern California.

Dr. Francis is an examiner for the American Board of Ophthalmology, and has been honored by the American Academy of Ophthalmology with an Achievement Award and Secretariat Award.

Dr. Francis recently became the inaugural holder of the Ralph and Angelyn Riffenburgh Professorship in Glaucoma (2008). He also serves on the Ophthalmic Technology Assessment Committee of the AAO, evaluating newer technologies in glaucoma. He is on the editorial board and a section editor of Eyenet Magazine, and the glaucoma section editor for Ophthalmology Web. Dr. Francis is involved in clinical trials of glaucoma diagnostic technologies, medications and surgical procedures and has published over 40 publications in peer reviewed journals, and has authored several book chapters, and has published on the epidemiology of glaucoma and related risk factors.

Contact Dr. Francis at: bfrancis@usc.edu

Advantages of Selecta® II for SLT Laser Therapy

  • Safe, office-based procedure 5
  • Proven to reduce IOP 1,10, 11,13
  • No systemic side effects 2, 13
  • Effective as primary, adjunctive, or replacement 4, 9,11,13
  • A single treatment therapy that is safe to repeat as needed.3, 4, 8,12, 13
  • Patient compliance is not an issue,13,14
  • Preserves trabecular meshwork 6, 8,13
  • Medicare reimbursed 7

References

1) P Lanzetta, U Menchini, G Virgili. Immediate intraocular pressure response to selective laser trabeculoplasty. Fr. J. Ophthalmol., Jan 1999; 83: 29-32.
2) Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (Selective Laser Trabeculoplasty). Ophthalmology 1998; 105:2082-2090.
3) FDA clearance; 510(k) Number K021550
4) S. Melamed MD, g.J. Ben Simon MD, H. Levkovitch-Verbin MD. Selective Laser Trabeculoplasty as Primary Treatment for Openangle Glaucoma. A Prospective, Nonrandomized Pilot Study. Arch Ophthalmol. 2003;
121:957-960.
5) Noecker RJ, Kramer TR. Comparison of the acute morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology, April 2001; 108(4):773-9.
6) Alvarado JA, Latina MA, Damji KF, Katz LJ. The Science Underlying Selective Laser Trabeculoplasty. Ophthalmology Management, June 2002.
7) Centers for Medicare and Medicaid Services
8) I. Ahmed, T. Realini, Preserving the trabecular meshwork. Glaucoma Today,, Jul/Aug 2005; 7-8
9) B. Francis, T. Ianchulev, J. Schofield, D. Minckler. Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma., Brief Reports 2005; Vol. 40, No. 3
10) S Qian, X Sun. Selective laser trabeculoplasty in treatment of primary open-angle glaucoma., Zhonghue yi xue zu zhi 2007 Jan 9;87 (2): 118-20
11) M Werner, M Smith, J Doyle. Selective laser trabeculoplasty in phakic and pseudophakic eyes., Ophthalmic Surg. Lasers Imaging 2007 May-June; 38(3):182-8
12) M Latina, J deleon. Safe well tolerated effective in lowering IOP. Ophthalmol Clin North Am 2005 Sep; 18(3):409-19 vi.
13) I. McIlraith, M. Strasfeld, G. Colev, C Hutnik. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma., J Glaucoma 2006 Apr; 15(2):124-30
14) A. Lefrancois. What should we think? Is selective laser trabeculoplasty more effective than conventional argon laser trabeculoplasty?, J Fr Ophthalmol 2007 May; 30(5pt2):3574-8

 

dots  Did you know that we record our eSeminars?

To view a past eSeminar recording, click here.

 
©2008 Lumenis Ophthalmology | Terms of Use | Legal Notice | Privacy Statement | Trademarks | Corporate